Skip to content

Effects of E-Cigarette Use Among Young Egyptian Adults

Respiratory, Functional, and Radiological Effects of E-Cigarette Use Among Young 1 Egyptian Adults: A Cross-Sectional Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07422415
Enrollment
104
Registered
2026-02-20
Start date
2025-09-01
Completion date
2026-02-01
Last updated
2026-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E Cigarette Use

Keywords

E-cigarettes, Vaping

Brief summary

Electronic cigarettes (E-cigarettes) have gained significant popularity as an alternative to traditional combustible tobacco cigarette smoking. E-cigarettes are marketed as a safer alternative to conventional smoking forms. Many chronic smokers suppose that e-cigarettes are risk-free and can be used effectively as a smoking cessation tool. The market size of e-cigarette is increasing because of its rising popularity among the youth even though it is not an approved Food and Drug Administration (FDA) product yet

Detailed description

Most daily life activities as walking and household chores that affect quality of life are performed at a submaximal level of exertion. E-cigarettes may affect overall physical fitness and cardiovascular health. It is important to evaluate responses of all body systems interacting during exercise, including cardiovascular and pulmonary function, systemic circulation, peripheral circulation, blood, neuromuscular units, muscle metabolism, oxygen transport and utilization within skeletal muscles. The knowledge gap regarding the potential negative health effects of E-cigarettes is crucial, as e-cigarettes are newly prevailing smoking tools that are gaining rising popularity among the youth. Additionally, the false perception of the unregulated electronic cigarette smoking as a safe recreational habit may increase the prevalence among the population. The aim of this work is to assess the clinical and functional impact of E-cigarettes garette use in young Egyptian adults, and to evaluate the role of chest CT in follow-up of identified abnormalities.

Interventions

DIAGNOSTIC_TESTPulmonary Function test

Spirometry was performed measure forced expiratiory volume at 1st second (FEV₁), forced vital capacity (FVC), and FEV₁/FVC ratio.

Sponsors

Mansoura University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Age \> 18 years * E-cigarette users (≥6 months of regular use) * No prior history of chronic pulmonary disease

Exclusion criteria

* Dual users (both e-cigarettes and traditional tobacco) * History of chronic respiratory illnesses (e.g., asthma, COPD) * immunocompromised * Systemic chronic diseases

Design outcomes

Primary

MeasureTime frameDescription
Spirometer parameters assessment3 monthsSpirometry was performed to measure forced expiratory volume at 1st second (FEV₁)
Spirometer assessment3 monthsSpirometry was performed to measure FEV₁/FVC ratio
Spirometer3 monthsSpirometry was performed to measure forced vital capacity (FVC)

Countries

Egypt

Contacts

PRINCIPAL_INVESTIGATORMohamed AbdElmoniem

Lecturer of chest medicine faculty of medicine Mansoura university

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026